The effect of lenvatinib in combination with chemotherapy plus immune checkpoint inhibitors on tumor microenvironments in the mouse syngeneic tumor model

被引：0
|
作者：
Kato, Yu
Ozawa, Yoichi
Adachi, Keito
Kume, Masahiko
Adachi, Yusuke
Narita, Yudai
Kuronishi, Megumi
Matsui, Junji
Yokoi, Akira
Funahashi, Yasuhiro
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5124
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Combination of IGF-1R targeted alpha therapy with checkpoint inhibitors results in synergistic efficacy in a syngeneic colorectal tumor model
    Patel, Sonal
    Grinshtein, Natalie
    Simms, Ryan
    Hu, Meiduo
    Valliant, John
    Burak, Eric
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [32] Combination of the angiogenesis inhibitor lucitanib with immune checkpoint blockade augments anti-tumor activity in syngeneic models
    Dusek, Rachel
    Robillard, Liliane
    Harding, Thomas
    Simmons, Andrew
    Minh Nguyen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [33] Combination of rapamycin with immune checkpoint blockade in a syngeneic breast carcinoma model
    Trachet, Erin
    Elders, Chris
    Urs, Sumithra
    Krueger, Sarah
    Wong, Alden
    Franklin, Maryland Rosenfeld
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Protocol to study the immune profile of syngeneic mouse tumor models
    Miyauchi, Sayuri
    Arimoto, Kei-ichiro
    Liu, Mengdan
    Zhang, Yue
    Zhang, Dong-Er
    STAR PROTOCOLS, 2024, 5 (03):
  • [35] Combination of immune checkpoint inhibitors plus chemotherapy and risk of pneumonitis: A worldwide retrospective pharmacovigilance study.
    Zheng, Yi-Fan
    Xu, Pei-Hang
    Li, Zi-Mu
    Kuang, Yu-Kun
    Li, Jia
    He, Jun-Hao
    Chen, Xiao
    Tang, Ke-Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] STAT3 inhibition enhances the activity of immune checkpoint inhibitors in murine syngeneic tumor models by creating a more immunogenic tumor microenvironment
    Woessner, Rich
    McCoon, Patricia
    Bell, Kirsten
    DuPont, Rachel
    Collins, Mike
    Lawson, Deborah
    Nadella, Prasad
    Pablo, Lourdes
    Reimer, Corinne
    Sah, Vasu
    Lyne, Paul
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [37] Pemetrexed Exerts Intratumor Immunomodulatory Effects and Enhances Efficacy of Immune Checkpoint Blockade in MC38 Syngeneic Mouse Tumor Model
    Novosiadly, R.
    Schaer, D.
    Lu, Z.
    Amaladas, N.
    Luo, S.
    Capen, A.
    Meyer, C.
    Manro, J.
    Donoho, G.
    Doman, T.
    Hall, G.
    Smeal, T.
    Kalos, M.
    Geeganage, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2300 - S2300
  • [38] The effect of intestinal flora on immune checkpoint inhibitors in tumor treatment: a narrative review
    Wang, Dan
    Hao, He
    Li, Xing
    Wang, Zhiyu
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (17)
  • [39] Antitumor activity of lenvatinib against acquired resistance tumor to anti-VEGF therapy in mouse syngeneic tumor models
    Ichikawa, Kenji
    Miyano, Saori Watanabe
    Minoshima, Yukinori
    Matsui, Junji
    Funahashi, Yasuhiro
    CANCER RESEARCH, 2019, 79 (13)
  • [40] Requirement of the Acquired Immune System in Successful Cancer Chemotherapy With cis-Diamminedichloroplatinum (II) in a Syngeneic Mouse Tumor Transplantation Model
    Taniguchi, Keisuke
    Nishiura, Hiroshi
    Yamamoto, Tetsuro
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (06) : 480 - 489
12345